Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acutaas ChemicalsNSE:ACUTAAS -1.43%72 3-Year EBITDA Growth Rate is 25.40% as of Jun. 2026, which is 22% below its 10-year median of 32.45. GuruFocus rates NSE:ACUTAAS with a GF Score™ of 72/100 and a GF Value™ of ₹1,386.19 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,409 Chemicals companies, Acutaas Chemicals ranks better than 84.95% on this metric.
During the past 12 months, Acutaas Chemicals's average EBITDA Per Share Growth Rate was 74.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 25.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 29.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Acutaas Chemicals was 42.70% per year. The lowest was 8.40% per year. And the median was 32.45% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Acutaas Chemicals 3-Year EBITDA Growth Rate Related Terms
NSE:ACUTAAS vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Acutaas Chemicals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutaas Chemicals 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Acutaas Chemicals's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Acutaas Chemicals's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 25.40% mean?
Acutaas Chemicals (NSE:ACUTAAS) has a 3-Year EBITDA Growth Rate of 25.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Acutaas Chemicals and its competitors. This is 22% below median its historical median of 32.45. Over the past decade, Acutaas Chemicals' 3-Year EBITDA Growth Rate has ranged from 8.40 to 42.70. According to the industry distribution chart, Acutaas Chemicals ranks #212 out of 1409 companies in the Chemicals industry, placing it in the top 15%.
Is Acutaas Chemicals' 3-Year EBITDA Growth Rate too high?
Acutaas Chemicals' current 3-Year EBITDA Growth Rate of 25.40% is 22% below median its 10-year median of 32.45. Over the past 10 years, this metric has ranged from a low of 8.40 to a high of 42.70. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. Acutaas Chemicals' value of 25.40% is 3075% above this industry median. Based on the distribution chart, Acutaas Chemicals ranks #212 out of 1409 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Acutaas Chemicals has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Acutaas Chemicals ranks #212 out of 1409 companies for 3-Year EBITDA Growth Rate. This places Acutaas Chemicals in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. Acutaas Chemicals' value of 25.40% is 3075% above this benchmark. Historically, Acutaas Chemicals' own 3-Year EBITDA Growth Rate has ranged from 8.40 to 42.70 over the past decade. While the company's 10-year median is 32.45 vs. the industry median of 0.80, Acutaas Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acutaas Chemicals's current 3-Year EBITDA Growth Rate of 25.40% is 3075% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Acutaas Chemicals and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acutaas Chemicals's current 3-Year EBITDA Growth Rate is 25.40%, which is 22% below median its own 10-year median of 32.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,386.19, compared to a current price of ₹3,281.60 — trading 136.7% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 25.40%, which is 22% below median its 10-year median of 32.45 and 3075% above the Chemicals industry median of 0.80. Acutaas Chemicals' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current 3-Year EBITDA Growth Rate is 25.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?
Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued.
The current stock price of ₹3,281.60 is trading 136.7% above its estimated GF Value™ of ₹1,386.19.
GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:ACUTAAS:
3-Year EBITDA Growth Rate: 25.40% (22% below median its 10-year median of 32.45)
GF Value™: ₹1,386.19 vs. price of ₹3,281.60 (136.7% above fair value)
Industry Position: 3075% above the Chemicals median (#212 of 1409)
No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
72GF Score
Get the complete analysis for NSE:ACUTAAS
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACUTAAS has been successfully added to your 
